Rituximab Doesn't Alleviate Sjögren Symptoms at Week 24 Doctors Lounge FRIDAY, Feb. 21, 2014 (HealthDay News) -- For patients with primary Sjögren syndrome (pSS), rituximab does not improve symptoms or disease activity at 24 weeks, according to a study published in the Feb. 18 issue of the Annals of Internal Medicine. |
